FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip

Abstract

The COVID-19 pandemic originating in the Wuhan province of China in late 2019 has impacted global health, causing increased mortality among elderly patients and individuals with comorbid conditions. During the passage of the virus through affected populations, it has undergone mutations, some of which have recently been linked with increased viral load and prognostic complexities. Several of these variants are point mutations that are difficult to diagnose using the gold standard quantitative real-time PCR (qRT-PCR) method and necessitates widespread sequencing which is expensive, has long turn-around times, and requires high viral load for calling mutations accurately. Here, we repurpose the high specificity of Francisella novicida Cas9 (FnCas9) to identify mismatches in the target for developing a lateral flow assay that can be successfully adapted for the simultaneous detection of SARS-CoV2 infection as well as for detecting point mutations in the sequence of the virus obtained from patient samples. We report the detection of the S gene mutation N501Y (present across multiple variant lineages of SARS-CoV2) within an hour using lateral flow paper strip chemistry. The results were corroborated using deep sequencing on multiple wild type (n=37) and mutant (n=22) viral RNA samples with a sensitivity of 87% and specificity of 97%. The design principle can be rapidly adapted for other mutations (as shown also for E484K and T716I) highlighting the advantages of quick optimization and roll-out of CRISPR diagnostics (CRISPRDx) for disease surveillance even beyond COVID-19. This study was funded by Council for Scientific and Industrial Research, India.

Data availability

Sequencing data associated with the manuscript have been deposited to GISAID with the following numbers:EPI_ISL_911542, EPI_ISL_911532, EPI_ISL_911543, EPI_ISL_911533, EPI_ISL_911544, EPI_ISL_911534, EPI_ISL_911545, EPI_ISL_911535, EPI_ISL_911546, EPI_ISL_911536, EPI_ISL_911547, EPI_ISL_911537, EPI_ISL_911538, EPI_ISL_911540, EPI_ISL_911541, EPI_ISL_911539 were just released and are now available to all participants in GISAID.

Article and author information

Author details

  1. Manoj Kumar

    in, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0772-1399
  2. Sneha Gulati

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  3. Asgar H Ansari

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  4. Rhythm Phutela

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  5. Sundaram Acharya

    IGIB, CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    No competing interests declared.
  6. Mohd Azhar

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    Mohd Azhar, Mohd. Azhar is currently an employee of TATA Medical and Diagnostics.
  7. Jayaram Murthy

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  8. Poorti Kathpalia

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  9. Akshay Kanakan

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  10. Ranjeet Maurya

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  11. Janani Srinivasa Vasudevan

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3381-5228
  12. Aparna Murali

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, Delhi, India
    Competing interests
    No competing interests declared.
  13. Rajesh Pandey

    CSIR Ayurgenomics Unit (TRISUTRA), CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    No competing interests declared.
  14. Souvik Maiti

    Chemical and Systems Biology, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India
    For correspondence
    souvik@igib.res.in
    Competing interests
    No competing interests declared.
  15. Debojyoti Chakraborty

    Genomics and Molecular Medicine, CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    For correspondence
    debojyoti.chakraborty@igib.in
    Competing interests
    Debojyoti Chakraborty, A patent application has been filed in relation to this work. (0127NF2019)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1460-7594

Funding

University Grants Commission (Graduate student fellowship)

  • Manoj Kumar

IUSSTF (CLP-0033)

  • Rajesh Pandey

CSIR Sickle Cell Anemia Mission (HCP0008)

  • Debojyoti Chakraborty

Tata Steel (SSP 2001)

  • Debojyoti Chakraborty

Lady Tata Young Investigator (GAP0198)

  • Debojyoti Chakraborty

CSIR Sickle Cell Anemia Mission (HCP0008)

  • Souvik Maiti

CSIR (Graduate Student fellowship)

  • Mohd Azhar

CSIR (Graduate Student fellowship)

  • Jayaram Murthy

CSIR (Research Associateship)

  • Sneha Gulati

Indian Council of Medical Research (Graduate Student fellowship)

  • Asgar H Ansari

CSIR (Graduate Student fellowship)

  • Rhythm Phutela

CSIR (Graduate Student fellowship)

  • Sundaram Acharya

CSIR (Research Associateship)

  • Poorti Kathpalia

CSIR (MLP 2005)

  • Rajesh Pandey

Fondation Botnar (CLP-0031)

  • Rajesh Pandey

Intel Corporation (CLP-0034)

  • Rajesh Pandey

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The present study was approved by the Ethics Committee, Institute of Genomics and Integrative Biology, New Delhi (CSIR-IGIB/IHEC/2020-21/01.)

Copyright

© 2021, Kumar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,264
    views
  • 741
    downloads
  • 59
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Manoj Kumar
  2. Sneha Gulati
  3. Asgar H Ansari
  4. Rhythm Phutela
  5. Sundaram Acharya
  6. Mohd Azhar
  7. Jayaram Murthy
  8. Poorti Kathpalia
  9. Akshay Kanakan
  10. Ranjeet Maurya
  11. Janani Srinivasa Vasudevan
  12. Aparna Murali
  13. Rajesh Pandey
  14. Souvik Maiti
  15. Debojyoti Chakraborty
(2021)
FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip
eLife 10:e67130.
https://doi.org/10.7554/eLife.67130

Share this article

https://doi.org/10.7554/eLife.67130

Further reading

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.